CoQ10 a super-vitamin: review on application and biosynthesis

Coenzyme Q10 (CoQ) or ubiquinone is found in the biological system which is synthesized by the conjugation of benzoquinone ring with isoprenoid chain of variable length. Coenzyme Q10 supplementation energizes the body and increases body energy production in the form of ATP and helps to treat various human diseases such as cardiomyopathy, muscular dystrophy, periodontal disease, etc. Reports of these potential therapeutic advantages of CoQ10 have resulted in its high market demand, which focus the researchers to work on this molecule and develop better bioprocess methods for commercial level production. At the moment, chemical synthesis, semi-synthetic method as well as bio-production utilizing microbes as biofactory are in use for the synthesis of CoQ10. Chemical synthesis involves use of cheap and easily available precursor molecules such as isoprenol, chloromethylquinone, vinylalane, and solanesol. Chemical synthesis methods due to the use of various solvents and chemicals are less feasible, which limits its application. The microbial production of CoQ10 has added advantages of being produced in optically pure form with high yield using inexpensive medium composition. Several bacteria, e.g., Agrobacterium, Paracoccus, Rhodobacterium, and yeast such as Candida, Rhodotorula are the potent ubiquinone producer. Some alternative biosynthetic pathway for designing of CoQ10 production coupled with metabolic engineering might help to increase CoQ10 production. The most common practiced strategy for strain development for commercial CoQ10 production is through natural isolation and chemical mutagenesis. Here, we have reviewed the chemical, semi-synthetic as well as microbial CoQ10 production in detail.

Assessing the influence of the carbon source on the abatement of industrial N2O emissions coupled with the synthesis of added-value bioproducts

The continuous abatement of a synthetic N₂O emission from a nitric acid plant coupled with the simultaneously production of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) copolymer and the coenzyme Q10 (CoQ₁₀) in a bubble column reactor (BCR) was tested using methanol, glycerol and a mixture of sodium acetate-acetic acid (Ac-HAc) as a carbon and electron donor source. The BCRs were inoculated with Paracoccus denitrificans and supplied with the carbon/electron donor at a loading rate of 139gCm^-3d^-1. High N₂O removal efficiencies (81-91%) were achieved, with glycerol supporting the highest abatement. The PHBV cell content ranged from 25 to 53%, with highest accumulation in the culture obtained with methanol and Ac-HAc. However, the greatest PHBV productivities were observed in the BCRs operated with glycerol and Ac-HAc (21.7 and 33.5gPHBVm^-3d^-1, respectively). Glycerol supply induced the highest molar ratio (23%) of the homopolymer 3-hydroxyvalerate in the composition of PHBV. In addition, the specific cell content of CoQ₁₀ ranged from 0.4 to 1mgg^-1. This work constitutes, to the best of our knowledge, the first study combining N₂O abatement with the simultaneous production of multiple bioproducts, which pave the way to the development of greenhouse gas biorefineries for climate change mitigation.